Immunohistochemical study of cyclooxygenase-2 in skin tumors

Journal of Dermatological Treatment

Volumn 25, Issue 5, 2014, Pages 380-387

  Amirnia, Mehdi ^a   Babaie Ghazani, Arash ^b   Fakhrjou, Ashraf ^b   Khodaeiani, Effat ^a   Alikhah, Hossein ^b   Naghavi Behzad, Mohammad ^b   Zarrintan, Armin ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Actinic keratosis (AK); Basal cell carcinomas (BCC); Bowen's disease (BD); Cyclooxygenase 2 (COX 2); Immunohistochemistry (IHC); Squamous cell carcinomas (SCC)

Indexed keywords

CYCLOOXYGENASE 2;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84890326841     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2012.674191     Document Type: Article

References (40)

1. Groot DJ, Vries EG, Groen HJ, Jong S. Non-steroidal antiinflammatory drugs to potentiate chemotherapy effects: From lab to clinic. Crit Rev Oncol Hematol. 2007;61:52-69
2. Kagoura M, Toyoda M, Matsui C, Morohashi M. Immunohistochemical expression of cyclooxygenase-2 in skin cancers. J Cutan Pathol. 2001;28:298-302
3. Nijsten T, Colpaert CG, Vermeulen PB, Harris AL, Van Marck E, Lambert J. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: A paired immunohistochemical study of 35 cases. Br J Dermatol. 2004;151:837-845
4. Kim KH, Park EJ, Seo YJ, Cho HS, Kim CW, Kim KJ, et al. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. J Dermatol. 2006;33:319-312
5. Muller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Furstenberger G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci USA. 2002;99:12483-12488
6. Meric JB, Rottey S, Olaussen K, Soria JC, Khayat D, Rixe O, et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol. 2006;59:51-64
7. Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 2004;18:300-310
8. Thun MJ, Henley SJ, Patrono C. Nonsteroidal antiinflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94: 252-266
9. Fischer SM, Conti CJ, Viner J, Aldaz CM, Lubet RA. Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis. 2003;24:945-952
10. Airton G, LorivaldoM. Risk factors for basal cell carcinoma in a southern Brazilian population: A case-control study. Int J Dermatol. 2011;50:1286-1290
11. Khodaeiani E, Amirnia M, Babaei-Nazhad S, Esmaeili H, Razzagh-Karimi E, Alikhah H. Clinicopathologic study of basal cell carcinoma. Res J Biol Sci. 2010;5:293-296
12. Babaye-Nazhad S, Amirnia M, Alikhah H, Khodaeyani E, Atapour N. Safety margin in excision of basal cell carcinoma. Pak J Biol Sci. 2009;12:1408-1414
13. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol. 2006;155:9-22
14. Schwartz RA. Chapter 5. Squamous cell carcinoma. Skin Cancer: Recognition and Management. 2nd ed. Blackwell Publishing, 2008
15. Schwartz RA. Chapter 4. Bowen's disease. Skin Cancer: RecognitionandManagement. 2nded. BlackwellPublishing,2008
16. Khuder SA, Mutgi AB. Breast cancer and NSAID use: A meta-analysis. Br J Cancer. 2001;84:1188-1192
17. Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer. 2000;82:1364-1369
18. Irani J, Ravery V, Pariente JL, Chartier-Kastler E, Lechevallier E, Soulie M, et al. Effect of nonsteroidal antiinflammatory agents and finasteride on prostate cancer risk. J Urol. 2002;168:1985-1988
19. Muscat JE, Chen SQ, Richie JP Jr, Altorki NK, Citron M, Olson S, et al. Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. Cancer. 2003;97:1732-1736
20. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci USA. 2002;99:13926-13931
21. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem. 2001; 276:18563-18569
22. Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville-Nash PR, Willis D, et al. The inhibition of colon-26 adenocarcinomadevelopment andangiogenesis bytopicaldiclofenac in 2.5% hyaluronan. Cancer Res. 1997;57:1625-1629
23. Karuppu D, Kalus A, Simpson ER, Clyne C. Aromatase and prostaglandin inter-relationships in breast adipose tissue: Significance for breast cancer development. Breast Cancer Res Treat. 2002;76:103-109
24. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 1997;94:3336-3340
25. Higashi Y, Kanekura T, Kanzaki T. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression. Int J Cancer. 2000;86:667-671
26. Huang C, Ma WY, Hanenberger D, Cleary MP, Bowden GT, Dong Z. Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Biol Chem. 1997;42:325-331
27. Müller-Decker K, Reinerth G, Krieg P, Zimmermann R, Heise H, Bayerl C, Marks F, Fürstenberger G. Prostaglandin- H-synthase isozyme expression in normal and neoplastic human skin. Int J Cancer. 1999;82:648-656
28. Turini ME, DuBois RN. Cyclooxygenase-2: A therapeutic target. Annu Rev Med. 2002;53:35-57
29. Siegle I, Klein T, Backman JT, Saal JG, Nüsing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: Differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 1998;41: 122-129
30. Kandil HM, Tanner G, Smalley W, Halter S, Radhika A, Dubois RN. Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci. 2001;46:785-789
31. Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci. 2000;30:3-21
32. Dannenberg AJ, Altorki NK, Boyle JO, Lin DT, Subbaramaiah K. Inhibition of cyclooxygenase-2: An approach to preventing cancer of the upper aerodigestive tract. Ann NY Acad Sci. 2001;952:109-115
33. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest. 2000;105:1589-1594
34. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: Implications for tumor angiogenesis and metastasis. Neoplasia. 2001;3: 53-61
35. Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis. 1999;20: 1939-1944
36. Luo M, Lee S, Brock TG. Leukotriene synthesis by epithelial cells. Histol Histopathol. 2003;18:587-595
37. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000;60:6846-6850
38. Gallo O, Fabbroni V, Sardi I, Magnelli L, Boddi V, Franchi A. Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas. Biochem Biophys Res Commun. 2002;299:517-524
39. Moyisch KB, Menezes RJ, Ronani A, Swede H, Reid ME, Cummings KM, et al. Regular aspirin use and lung cancer risk. BMC Cancer. 2002;2:31-38
40. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891-899